Pulse Biosciences
PLSE
47 hedge funds and large institutions have $15.6M invested in Pulse Biosciences in 2020 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 18 reducing their positions, and 3 closing their positions.
13,050% more call options, than puts
Call options by funds: $263K | Put options by funds: $2K
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
4% more funds holding
Funds holding: 45 → 47 (+2)
0.1% more ownership
Funds ownership: 10.49% → 10.6% (+0.1%)
47% less capital invested
Capital invested by funds: $29.3M → $15.6M (-$13.6M)
50% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JMPWA
JP Morgan Private Wealth Advisors
San Francisco,
California
|
+$442K |
| 2 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$180K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$130K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$109K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$73.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TF
TIAA FSB
Jacksonville,
Florida
|
-$366K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$170K |
| 3 |
Morgan Stanley
New York
|
-$147K |
| 4 |
BlackRock
New York
|
-$109K |
| 5 |
Barclays
London,
United Kingdom
|
-$77.8K |
PLSE Hedge Fund Activity: Q1 2020 in Review
47 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Pulse Biosciences (PLSE) for Q1 2020, worth a combined $15.6M — down 47% from $29.3M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new PLSE positions and 3 closed out — a net gain of 4 holders — while 9 added to existing stakes and 18 trimmed.
The largest buyer was JP Morgan Private Wealth Advisors, opening a new position worth an estimated $442K. The largest seller was TIAA FSB, exiting entirely with an estimated $366K sold.
- 47 institutional investors held Pulse Biosciences (PLSE) as of Q1 2020, up from 45 in Q4 2019.
- Funds reported $15.6M of Pulse Biosciences stock for Q1 2020, down 47% quarter-over-quarter.
- 7 funds opened new Pulse Biosciences positions in Q1 2020 and 3 closed out, a net change of +4 holders.
- The largest Pulse Biosciences buyer in Q1 2020 was JP Morgan Private Wealth Advisors, an estimated $442K added.
- The largest Pulse Biosciences seller in Q1 2020 was TIAA FSB, an estimated $366K sold.
Based on aggregated 13F filings for Q1 2020.